BARCELONA, Spain, Nov. 4, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest albumin ...
Infection and increased systemic inflammation cause organ dysfunction and death in patients with decompensated cirrhosis. Preclinical studies provide support for an antiinflammatory role of albumin, ...
Please provide your email address to receive an email when new articles are posted on . Targeted human albumin solution increased serum sodium in hospitalized patients with cirrhosis and hyponatremia, ...
Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver disease, over and above 'standard care', finds a large-scale multicentre trial led by UCL ...
JUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results